This section is current as of June 2026
The FDA placed it on a Category 2 do-not-compound list in 2023 over impurity and immune-reaction concerns, so no licensed compounding pharmacy can prepare it either
vials run $199$599
*Correspondence: Qilai Huang, [email protected] These authors contributed equally to this work This article was submitted to Cellular Biochemistry, a section of the journal Frontiers in Molecular Biosciences Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Since capsules go through the digestive system, less of the peptide may reach the rest of the body compared to an injection
Corsini EM, Foo WC, Mitchell KG, Zhou N, Maru DM, Ajani JA, Hofstetter WL, Correa AM, Antonoff MB, Lin SH, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG , Vaporciyan AA, Walsh GL